1.
J Eur Acad Dermatol Venereol
; 34(9): e433-e434, 2020 Sep.
Article
in English
| MEDLINE | ID: covidwho-601286
2.
J Am Acad Dermatol
; 83(3): e251-e252, 2020 09.
Article
in English
| MEDLINE | ID: covidwho-592491
Subject(s)
Antibodies, Monoclonal, Humanized/adverse effects , Betacoronavirus/immunology , Coronavirus Infections/epidemiology , Dermatitis, Atopic/drug therapy , Pneumonia, Viral/epidemiology , COVID-19 , Clinical Decision-Making , Coronavirus Infections/immunology , Coronavirus Infections/prevention & control , Coronavirus Infections/virology , Dermatitis, Atopic/immunology , Dermatology/standards , Humans , Interleukin-4 Receptor alpha Subunit/antagonists & inhibitors , Interleukin-4 Receptor alpha Subunit/immunology , Pandemics/prevention & control , Pneumonia, Viral/immunology , Pneumonia, Viral/prevention & control , Pneumonia, Viral/virology , Practice Guidelines as Topic , Randomized Controlled Trials as Topic , Risk Assessment , SARS-CoV-2 , Treatment Outcome
3.
J Eur Acad Dermatol Venereol
; 34(7): e303-e304, 2020 Jul.
Article
in English
| MEDLINE | ID: covidwho-116729